Researchers have developed aptamers that block the immune protein CCL22, crucial in allergic reactions, from attracting T-cells to the site of inflammation. This targeted approach is a significant advancement in allergy treatment by addressing specific molecular mechanisms rather than broadly suppressing the immune system. Promising results in mice suggest potential uses beyond allergic contact dermatitis, including atopic dermatitis and malignant melanoma. Though limited to animal studies, ongoing research aims to determine efficacy in humans. Additionally, Anna's archive, a shadow library for pirated books and academic papers, faces challenges in the debate between open access to information and copyright protection.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode